24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
V-Wave
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:49
Vietnam to produce Rafael Spike missiles locally in $250 million deal
18:36
Wiz finds major flaw in Moltbook, the vibe-coded social network for AI bots
18:22
CTech opens 2026 with 1 million unique visitors per month and 2.5 million page views
14:31
Shawarma and rubble: The paradox of Gaza’s post-war recovery
More stories
Buzz
Most popular
Daily
Weekly
1
Why Apple paid billions for a company with no revenue
2
Valued at $800 million after less than two years, Vega eyes the path blazed by Wiz
3
Israeli startups raise over $1 billion in January, marking best opening month since 2022
4
Google-Wiz deal expected to be cleared by EU following meeting with regulators, report says
5
From secret satellites to civilian services: Israel’s space industry reinvents itself
More news
V-Wave
6 stories about V-Wave
J&J’s $1.7 billion bet on Israeli heart device falters after FDA panel vote
10.12.25
|
CTech
Advisors reject effectiveness of V-Wave’s implant, threatening the contingent value of last year’s acquisition.
Riding the V-Wave exit: Who are the big winners?
21.08.24
|
Meir Orbach
The pharmaceutical giant Johnson & Johnson announced on Tuesday the purchase of the Israeli medical device company for up to $1.7 billion. BRM is the largest shareholder in the company and is expected to receive at least $100 million. The second largest shareholder is Pontifax VC of Tomer Kariv and Ran Nussbaum. Other notable investors include Ilan Grinboim and Prof. Benad Goldwasser.
Johnson & Johnson to acquire Israeli medical device maker V-Wave for up to $1.7 billion
20.08.24
|
Meir Orbach
V-Wave's device is implanted in the heart through a minimally invasive procedure to help reduce heart failure and other events.
Israel-based V-Wave raises $98 million for heart failure beating shunt
23.09.20
|
Meir Orbach
Group of global healthcare investors backs the company as it gears up for clinical trials
These Ten Israeli Companies Raised the Most Money in 2018
03.07.18
|
Orr Hirschauge
CTech takes a look at the biggest funding rounds of the past six months
Israeli Medical Device Developer V-Wave Raises $70 Million
26.04.18
|
Meir Orbach
V-Wave develops a minimally invasive implanted shunt device for treating patients with severe heart failure